The average retail price of Reclast is approximately $400 to $700 for a single infusion [1][2]. However, this cost can vary significantly based on factors such as the pharmacy, insurance coverage, and the specific dosage prescribed by a healthcare provider [1][2].
How does insurance affect the cost of Reclast?
Insurance plans can substantially reduce the out-of-pocket expense for Reclast. Many insurance providers cover a portion of the drug's cost, with patient responsibility often limited to a co-pay or co-insurance amount [1][2]. It is advisable for patients to verify their specific coverage details with their insurance company and discuss potential patient assistance programs with their doctor or pharmacist [1][2].
Are there patient assistance programs for Reclast?
Yes, patient assistance programs may be available to help reduce the cost of Reclast for eligible individuals who lack adequate insurance coverage or face high out-of-pocket expenses [1][2]. Information on these programs can often be found through the drug manufacturer's website or by inquiring with healthcare providers [1][2].
What is Reclast used for?
Reclast, also known by its generic name zoledronic acid, is primarily used to treat osteoporosis in postmenopausal women, men, and individuals with glucocorticoid-induced osteoporosis. It is also used to treat Paget's disease of bone and to prevent skeletal events (such as fractures) in patients with bone metastases from solid tumors [3].
How does Reclast work?
Reclast is a bisphosphonate that works by slowing down bone loss. It inhibits osteoclast activity, the cells responsible for breaking down bone tissue, thereby helping to increase bone mineral density and reduce the risk of fractures [3].
When does the patent for Reclast expire?
The patent exclusivity for Reclast has expired in many regions, allowing for the potential development and availability of generic versions [4]. Information regarding specific patent expiry dates for Reclast can be found on resources like DrugPatentWatch.com [4].
Who manufactures Reclast?
Reclast is manufactured by Novartis [3].
What are the potential side effects of Reclast?
Common side effects of Reclast can include flu-like symptoms, fever, muscle pain, and fatigue following the infusion [3]. More serious, though less common, side effects can include kidney problems, severe bone pain, and osteonecrosis of the jaw [3]. Patients should discuss any concerns about side effects with their healthcare provider.
What alternatives exist for treating osteoporosis?
Besides Reclast, other treatments for osteoporosis include other bisphosphonates (oral and injectable), denosumab, teriparatide, abaloparatide, and hormone therapy, among others [3]. The choice of treatment depends on individual patient factors, medical history, and the severity of the condition [3].
What is the difference between Reclast and other osteoporosis medications?
Reclast is an intravenous infusion, typically administered once a year for osteoporosis, which differentiates it from many oral bisphosphonates taken daily, weekly, or monthly [3]. Its mechanism of action as a bisphosphonate is similar to other drugs in its class, but administration and dosing schedules vary [3].
*
**Sources:
[1] https://www.goodrx.com/reclast
[2] https://www.webmd.com/drugs/2/201790/reclast-oral-capsule
[3] https://www.drugs.com/reclast.html
[4] https://drugpatentwatch.com